BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28

• Business

  Collegium Reports Fourth Quarter and Full-Year 2022 Financial Results

  Collegium Pharmaceutical, Inc. today reported its financial results for the quarter and full-year ended December 31, 2022 and provided a corporate update.

  February 23, 2023

   · 

  20 min read
• Drug Development

  Codexis and Nestlé Health Science Announce Interim Results from Phase 1 Clinical Trial of CDX-7108 for Exocrine Pancreatic Insufficiency

  Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, and Nestlé Health Science, a leader in the science of nutrition, today announced interim results from a Phase 1 study to investigate the safety, tolerability, pharmacokinetics (PK), and pharmacodynamics of CDX-7108.

  February 23, 2023

   · 

  5 min read
• Business

  Iridex to Report Fourth Quarter and Full Year 2022 Financial Results on March 9, 2023

  Iridex Corporation today announced the Company will release financial results for the fourth quarter and full year 2022 after the close of trading on Thursday, March 9, 2023.

  February 23, 2023

   · 

  1 min read
• Business

  OPKO Health Reports Fourth Quarter 2022 Business Highlights and Financial Results

  OPKO Health, Inc. (NASDAQ: OPK) reports business highlights and financial results for the three months ended December 31, 2022.

  February 23, 2023

   · 

  9 min read
• Business

  Codexis Reports Fourth Quarter and Fiscal Year 2022 Financial Results

  Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced financial results for the fourth quarter and fiscal year ended December 31, 2022.

  February 23, 2023

   · 

  18 min read
• Business

  Travere Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results

  Travere Therapeutics, Inc. (NASDAQ: TVTX) today reported its fourth quarter and full year 2022 financial results and provided a corporate update.

  February 23, 2023

   · 

  26 min read
• Deals

  Enochian BioSciences Announces Receipt of Notice from Nasdaq Regarding Delayed Filing of Form 10-Q for the Period Ended December 31, 2022

  On February 16, 2023, Enochian BioSciences Inc. (the “Company”) received a notice (the “Notice”) from The Nasdaq Stock Market LLC (“Nasdaq”) stating that because the Company has not yet filed its Form 10-Q for the period ended December 31, 2022.

  February 23, 2023

   · 

  2 min read
• Business

  Bausch Health Announces Fourth-Quarter and Full-Year 2022 Results

  Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) today announced its fourth-quarter and full-year 2022 financial results.

  February 23, 2023

   · 

  53 min read
• Genetown

  Ocean Biomedical (NASDAQ: OCEA) Celebrates Discovery of Bispecific Antibodies and Immune Checkpoint Inhibitors That Kill Glioblastoma Cells and Melanoma Cells, and Block the Metastasis of Malignant Melanoma Cells to the Lung by Over 90%

  As previously announced, Ocean Biomedical, Inc. celebrates the discovery of bispecific antibodies that target Chitinase 3-like-1 and immune checkpoint inhibitors, killing glioblastoma cells and melanoma cells,and blocking the metastasis of malignant melanoma cells to the lung by over 90%.

  February 23, 2023

   · 

  10 min read
• Business

  Baudax Bio Reports 2022 Fourth Quarter and Annual Financial Results and Provides Business Update

  Baudax Bio, Inc. today reported financial results for the fourth quarter and year ended December 31, 2022, updated the status of the neuromuscular blocking (NMB) agent development program, and provided an overview of other corporate and financial developments.

  February 23, 2023

   · 

  19 min read